Application 206641

Type
ANDA
Sponsor
ZYDUS PHARMS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL120MGNoNo
002DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL180MGNoNo
003DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL240MGNoNo
004DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL300MGNoNo
005DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL360MGNoNo
006DILTIAZEM HYDROCHLORIDEDILTIAZEM HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL420MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
68382-745TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-745TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-745TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-746TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-746TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-746TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-747TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-747TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-747TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-748TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-748TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-748TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-749TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-749TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-749TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-750TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-750TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-750TIADYLT ERdiltiazem hydrochlorideZydus Pharmaceuticals (USA) Inc.ANDACurrent
70771-1035TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1035TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1035TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1036TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1036TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1036TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1037TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1037TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1037TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1038TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1038TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1038TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1039TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1039TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1039TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1040TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1040TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent
70771-1040TIADYLT ERdiltiazem hydrochlorideCadila Healthcare LimitedANDACurrent

Documents

DocumentSubmission typeDate
49481ORIG2017-08-21